VXRT (Vaxart Inc.) יחס שווי שוק לשווי בספרים

Vaxart, Inc. (VXRT) relies on its own cGMP line in California while delegating mass production to global CMO partners. Geopolitical tensions and pandemic risks are driving government orders, and FDA support is streamlining the development of the tablet vaccine ecosystem. The company's relative capitalization metric reflects the market premium trend, where 1.57 serves as the final mark for the current asset valuation level.

Assessing the asset quality of Vaxart, Inc. (VXRT) requires analyzing the gap between market expectations and the actual value of its property. This ratio of the company's market value to its balance sheet assets measures the premium investors are willing to pay over net equity. A high coefficient reflects market confidence in robotic vaccine production lines that eliminate human error. Sharp spikes in this indicator signal speculative overheating, while a stable trend confirms the fundamental resilience of the capital.